Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamins | 34 | 2024 | 1623 | 4.210 |
Why?
|
Cacao | 11 | 2024 | 98 | 3.240 |
Why?
|
Dietary Supplements | 43 | 2024 | 3296 | 3.230 |
Why?
|
Hypertension | 44 | 2019 | 8479 | 2.820 |
Why?
|
Cardiovascular Diseases | 64 | 2023 | 15160 | 2.650 |
Why?
|
Carotenoids | 12 | 2014 | 624 | 2.450 |
Why?
|
Blood Pressure | 28 | 2021 | 8551 | 1.690 |
Why?
|
Body Mass Index | 58 | 2021 | 12721 | 1.480 |
Why?
|
Vitamin D | 16 | 2023 | 3224 | 1.470 |
Why?
|
C-Reactive Protein | 17 | 2023 | 3778 | 1.340 |
Why?
|
Flavonoids | 5 | 2021 | 443 | 1.320 |
Why?
|
Pancreatic Neoplasms | 29 | 2023 | 5263 | 1.300 |
Why?
|
Risk Factors | 162 | 2024 | 72296 | 1.280 |
Why?
|
Overweight | 12 | 2020 | 2371 | 1.250 |
Why?
|
Testicular Neoplasms | 11 | 2024 | 806 | 1.230 |
Why?
|
Alcohol Drinking | 21 | 2019 | 3966 | 1.210 |
Why?
|
Prospective Studies | 133 | 2024 | 53290 | 1.190 |
Why?
|
Diet | 23 | 2023 | 7937 | 1.180 |
Why?
|
Calcium, Dietary | 5 | 2016 | 526 | 1.160 |
Why?
|
Motor Activity | 14 | 2015 | 2715 | 1.130 |
Why?
|
Middle Aged | 247 | 2024 | 213390 | 1.120 |
Why?
|
Aged | 212 | 2024 | 163288 | 1.050 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2023 | 1344 | 1.050 |
Why?
|
Prostatic Neoplasms | 44 | 2022 | 11126 | 1.030 |
Why?
|
Antioxidants | 11 | 2014 | 1659 | 1.020 |
Why?
|
Proportional Hazards Models | 54 | 2021 | 12356 | 0.990 |
Why?
|
Double-Blind Method | 38 | 2024 | 12025 | 0.980 |
Why?
|
Vitamin E | 10 | 2022 | 869 | 0.970 |
Why?
|
Obesity | 29 | 2024 | 12746 | 0.960 |
Why?
|
Feeding Behavior | 12 | 2019 | 3188 | 0.950 |
Why?
|
Dairy Products | 6 | 2017 | 498 | 0.950 |
Why?
|
Smoking | 33 | 2021 | 8987 | 0.910 |
Why?
|
beta Carotene | 14 | 2023 | 527 | 0.910 |
Why?
|
Weight Gain | 9 | 2020 | 2293 | 0.910 |
Why?
|
Women's Health | 8 | 2016 | 2034 | 0.900 |
Why?
|
Physicians | 25 | 2022 | 4567 | 0.870 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2020 | 548 | 0.840 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2023 | 15520 | 0.840 |
Why?
|
Cause of Death | 17 | 2018 | 3582 | 0.840 |
Why?
|
Ascorbic Acid | 7 | 2022 | 651 | 0.830 |
Why?
|
Fruit | 6 | 2017 | 1142 | 0.830 |
Why?
|
Humans | 346 | 2024 | 744366 | 0.810 |
Why?
|
Male | 248 | 2024 | 350115 | 0.800 |
Why?
|
Life Style | 17 | 2022 | 3835 | 0.780 |
Why?
|
Stroke | 17 | 2022 | 9981 | 0.780 |
Why?
|
Follow-Up Studies | 71 | 2024 | 39052 | 0.770 |
Why?
|
Neoplasms | 27 | 2023 | 21696 | 0.760 |
Why?
|
Exercise | 24 | 2024 | 5615 | 0.760 |
Why?
|
Cataract | 3 | 2024 | 834 | 0.750 |
Why?
|
Case-Control Studies | 67 | 2023 | 21748 | 0.750 |
Why?
|
Randomized Controlled Trials as Topic | 37 | 2024 | 9955 | 0.720 |
Why?
|
Vitamin D Deficiency | 4 | 2022 | 1343 | 0.720 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2023 | 11726 | 0.710 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2020 | 227 | 0.690 |
Why?
|
Fishes | 3 | 2019 | 569 | 0.690 |
Why?
|
Myocardial Infarction | 19 | 2022 | 11718 | 0.690 |
Why?
|
Aspirin | 18 | 2022 | 3283 | 0.680 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 318 | 0.660 |
Why?
|
Incidence | 48 | 2023 | 20952 | 0.660 |
Why?
|
Cohort Studies | 70 | 2024 | 40559 | 0.650 |
Why?
|
Food Analysis | 2 | 2012 | 104 | 0.650 |
Why?
|
Cholangiocarcinoma | 6 | 2020 | 516 | 0.640 |
Why?
|
Bile Duct Neoplasms | 6 | 2019 | 567 | 0.640 |
Why?
|
Multivariate Analysis | 29 | 2020 | 12244 | 0.640 |
Why?
|
Female | 174 | 2024 | 380193 | 0.630 |
Why?
|
Risk | 36 | 2015 | 9688 | 0.630 |
Why?
|
Inflammation | 15 | 2023 | 10637 | 0.630 |
Why?
|
Coronary Disease | 19 | 2012 | 6077 | 0.620 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2018 | 238 | 0.620 |
Why?
|
Cholecalciferol | 6 | 2023 | 535 | 0.590 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2016 | 1159 | 0.590 |
Why?
|
Fatty Acids, Monounsaturated | 4 | 2016 | 194 | 0.590 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 129 | 0.580 |
Why?
|
Risk Assessment | 42 | 2021 | 23336 | 0.570 |
Why?
|
Vegetables | 6 | 2017 | 1182 | 0.570 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 167 | 0.560 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1888 | 0.560 |
Why?
|
Avitaminosis | 1 | 2016 | 34 | 0.560 |
Why?
|
Health Behavior | 6 | 2019 | 2635 | 0.560 |
Why?
|
Nutritional Status | 5 | 2022 | 1609 | 0.550 |
Why?
|
Liver Neoplasms | 10 | 2023 | 4253 | 0.540 |
Why?
|
Gout | 1 | 2022 | 573 | 0.530 |
Why?
|
United States | 75 | 2022 | 69872 | 0.530 |
Why?
|
Calcium | 4 | 2015 | 5755 | 0.520 |
Why?
|
Tinnitus | 4 | 2023 | 195 | 0.510 |
Why?
|
Waist Circumference | 8 | 2021 | 917 | 0.500 |
Why?
|
alpha-Tocopherol | 6 | 2019 | 127 | 0.500 |
Why?
|
Adult | 128 | 2024 | 214052 | 0.500 |
Why?
|
Aged, 80 and over | 71 | 2021 | 57776 | 0.490 |
Why?
|
Odds Ratio | 29 | 2019 | 9849 | 0.490 |
Why?
|
Postmenopause | 7 | 2020 | 2460 | 0.490 |
Why?
|
Physical Fitness | 7 | 2004 | 732 | 0.470 |
Why?
|
Dementia | 3 | 2023 | 2518 | 0.470 |
Why?
|
Mortality | 8 | 2014 | 2864 | 0.470 |
Why?
|
Genetic Predisposition to Disease | 26 | 2023 | 17446 | 0.470 |
Why?
|
Erythrocytes | 2 | 2015 | 2455 | 0.460 |
Why?
|
Dietary Fats | 5 | 2015 | 2016 | 0.460 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2021 | 1636 | 0.460 |
Why?
|
Adiponectin | 4 | 2023 | 1101 | 0.450 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 167 | 0.450 |
Why?
|
Interleukin-6 | 7 | 2020 | 3203 | 0.450 |
Why?
|
Kynurenine | 4 | 2023 | 139 | 0.440 |
Why?
|
Breast Neoplasms, Male | 4 | 2015 | 210 | 0.440 |
Why?
|
Cholesterol, HDL | 13 | 2016 | 1813 | 0.430 |
Why?
|
Fibrinogen | 1 | 2016 | 894 | 0.430 |
Why?
|
Lipids | 8 | 2019 | 3307 | 0.430 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2024 | 501 | 0.430 |
Why?
|
Plant Extracts | 5 | 2023 | 471 | 0.420 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12262 | 0.420 |
Why?
|
Ethanol | 2 | 2014 | 1342 | 0.420 |
Why?
|
Tea | 4 | 2005 | 275 | 0.410 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 348 | 0.400 |
Why?
|
Testosterone | 2 | 2020 | 2419 | 0.390 |
Why?
|
Fragaria | 2 | 2008 | 21 | 0.390 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2011 | 546 | 0.390 |
Why?
|
Congenital Abnormalities | 1 | 2016 | 707 | 0.390 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2020 | 2214 | 0.380 |
Why?
|
Vitamin A | 4 | 2017 | 615 | 0.380 |
Why?
|
Aging | 7 | 2015 | 8664 | 0.370 |
Why?
|
Hearing Loss | 4 | 2023 | 765 | 0.360 |
Why?
|
Carcinoma, Large Cell | 3 | 2019 | 113 | 0.360 |
Why?
|
Walking | 7 | 2009 | 1180 | 0.360 |
Why?
|
Survivors | 5 | 2024 | 2291 | 0.350 |
Why?
|
Coffee | 3 | 2020 | 578 | 0.350 |
Why?
|
Diastole | 4 | 2018 | 791 | 0.340 |
Why?
|
Antibodies, Bacterial | 3 | 2021 | 1470 | 0.340 |
Why?
|
Colorectal Neoplasms | 10 | 2021 | 6773 | 0.340 |
Why?
|
Cognition | 8 | 2024 | 6770 | 0.340 |
Why?
|
Energy Intake | 7 | 2016 | 2148 | 0.330 |
Why?
|
Lung Neoplasms | 14 | 2023 | 13104 | 0.330 |
Why?
|
Mendelian Randomization Analysis | 5 | 2023 | 967 | 0.330 |
Why?
|
Gonadal Steroid Hormones | 3 | 2020 | 711 | 0.320 |
Why?
|
Anticarcinogenic Agents | 2 | 2012 | 253 | 0.320 |
Why?
|
Hypercholesterolemia | 4 | 2023 | 1151 | 0.320 |
Why?
|
Systole | 4 | 2018 | 958 | 0.320 |
Why?
|
Health Promotion | 5 | 2022 | 2205 | 0.320 |
Why?
|
Poultry | 1 | 2008 | 82 | 0.310 |
Why?
|
Sex Factors | 15 | 2022 | 10400 | 0.310 |
Why?
|
Helicobacter pylori | 2 | 2023 | 383 | 0.310 |
Why?
|
Helicobacter Infections | 2 | 2023 | 387 | 0.300 |
Why?
|
Health | 1 | 2010 | 394 | 0.300 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2017 | 1186 | 0.300 |
Why?
|
Vitamin B 6 | 3 | 2018 | 237 | 0.300 |
Why?
|
Food Handling | 1 | 2007 | 145 | 0.290 |
Why?
|
Telomerase | 4 | 2016 | 730 | 0.290 |
Why?
|
Minerals | 4 | 2024 | 275 | 0.290 |
Why?
|
Diabetes Mellitus | 7 | 2024 | 5749 | 0.290 |
Why?
|
Gallbladder Neoplasms | 2 | 2019 | 182 | 0.290 |
Why?
|
Cholesterol | 10 | 2016 | 2919 | 0.280 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2020 | 188 | 0.280 |
Why?
|
Endothelium, Vascular | 4 | 2015 | 4459 | 0.280 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 6 | 2022 | 2282 | 0.270 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1213 | 0.270 |
Why?
|
Linear Models | 5 | 2018 | 5953 | 0.270 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2022 | 1581 | 0.270 |
Why?
|
Cisplatin | 7 | 2023 | 1662 | 0.270 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2016 | 403 | 0.270 |
Why?
|
Anthropometry | 5 | 2019 | 1350 | 0.270 |
Why?
|
Carbon | 2 | 2021 | 687 | 0.260 |
Why?
|
Adenocarcinoma | 8 | 2021 | 6364 | 0.260 |
Why?
|
Body Weight | 7 | 2015 | 4671 | 0.260 |
Why?
|
Age Factors | 16 | 2022 | 18373 | 0.260 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 1073 | 0.260 |
Why?
|
Men's Health | 2 | 2017 | 73 | 0.250 |
Why?
|
Meat | 1 | 2008 | 592 | 0.250 |
Why?
|
Genotype | 19 | 2021 | 12952 | 0.250 |
Why?
|
Disease Progression | 18 | 2021 | 13286 | 0.250 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4328 | 0.240 |
Why?
|
Adiposity | 5 | 2019 | 1806 | 0.240 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2019 | 388 | 0.240 |
Why?
|
Confidence Intervals | 9 | 2019 | 2971 | 0.240 |
Why?
|
Anthocyanins | 1 | 2024 | 79 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2021 | 8432 | 0.240 |
Why?
|
Breast Neoplasms | 6 | 2022 | 20824 | 0.230 |
Why?
|
Bile Ducts, Intrahepatic | 4 | 2020 | 295 | 0.230 |
Why?
|
Cotinine | 3 | 2018 | 206 | 0.230 |
Why?
|
Trace Elements | 2 | 2016 | 198 | 0.230 |
Why?
|
Fatty Acids | 3 | 2016 | 1809 | 0.220 |
Why?
|
Environment | 1 | 2009 | 1123 | 0.220 |
Why?
|
Logistic Models | 18 | 2018 | 13409 | 0.220 |
Why?
|
Diabetic Nephropathies | 2 | 2022 | 984 | 0.220 |
Why?
|
Life Expectancy | 2 | 2014 | 1184 | 0.220 |
Why?
|
Prostate-Specific Antigen | 6 | 2016 | 2494 | 0.220 |
Why?
|
Homocysteine | 1 | 2006 | 647 | 0.220 |
Why?
|
Body Size | 2 | 2017 | 461 | 0.220 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25039 | 0.220 |
Why?
|
Chronic Disease | 4 | 2023 | 9145 | 0.220 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 535 | 0.220 |
Why?
|
Leptin | 2 | 2023 | 1600 | 0.210 |
Why?
|
Migraine Disorders | 3 | 2023 | 1620 | 0.210 |
Why?
|
Risk Reduction Behavior | 5 | 2020 | 1125 | 0.210 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8038 | 0.210 |
Why?
|
Time Factors | 20 | 2021 | 40075 | 0.200 |
Why?
|
Health Surveys | 7 | 2019 | 4036 | 0.200 |
Why?
|
Seafood | 2 | 2019 | 384 | 0.200 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2016 | 357 | 0.200 |
Why?
|
Golf | 2 | 2000 | 16 | 0.200 |
Why?
|
Urban Population | 1 | 2009 | 2022 | 0.200 |
Why?
|
Energy Metabolism | 6 | 2013 | 2897 | 0.190 |
Why?
|
Xanthophylls | 4 | 2012 | 96 | 0.190 |
Why?
|
Diet Surveys | 1 | 2005 | 1173 | 0.190 |
Why?
|
Self Report | 5 | 2022 | 3553 | 0.190 |
Why?
|
Mosaicism | 2 | 2015 | 441 | 0.190 |
Why?
|
Eicosapentaenoic Acid | 3 | 2020 | 582 | 0.190 |
Why?
|
Lutein | 4 | 2012 | 125 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2949 | 0.180 |
Why?
|
Intermediate Filaments | 1 | 2021 | 175 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 11525 | 0.180 |
Why?
|
Markov Chains | 1 | 2003 | 969 | 0.180 |
Why?
|
Gene Frequency | 3 | 2018 | 3587 | 0.180 |
Why?
|
Receptors, Leptin | 2 | 2023 | 361 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2017 | 685 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2019 | 4034 | 0.180 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 326 | 0.180 |
Why?
|
Genetic Variation | 10 | 2019 | 6542 | 0.180 |
Why?
|
Fusobacterium nucleatum | 1 | 2021 | 163 | 0.180 |
Why?
|
Receptors, Somatomedin | 1 | 2018 | 57 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 3 | 2019 | 3143 | 0.170 |
Why?
|
Prognosis | 19 | 2022 | 29060 | 0.170 |
Why?
|
Estrone | 1 | 2020 | 240 | 0.170 |
Why?
|
Up-Regulation | 4 | 2015 | 4222 | 0.170 |
Why?
|
Bacterial Proteins | 4 | 2023 | 3854 | 0.170 |
Why?
|
Primary Prevention | 3 | 2019 | 1167 | 0.160 |
Why?
|
Kidney Neoplasms | 4 | 2019 | 4262 | 0.160 |
Why?
|
Glioma | 4 | 2015 | 3401 | 0.160 |
Why?
|
Quantitative Trait Loci | 3 | 2021 | 2019 | 0.160 |
Why?
|
Prostate | 3 | 2016 | 1775 | 0.160 |
Why?
|
Hormones | 2 | 2020 | 889 | 0.160 |
Why?
|
Nutrigenomics | 1 | 2018 | 23 | 0.160 |
Why?
|
Docosahexaenoic Acids | 3 | 2020 | 875 | 0.160 |
Why?
|
Health Status | 4 | 2018 | 4034 | 0.160 |
Why?
|
Receptors, Adiponectin | 2 | 2023 | 82 | 0.160 |
Why?
|
Mental Disorders | 2 | 2016 | 6598 | 0.150 |
Why?
|
Longevity | 3 | 2016 | 1071 | 0.150 |
Why?
|
Deficiency Diseases | 1 | 2018 | 72 | 0.150 |
Why?
|
Neuralgia | 1 | 2024 | 570 | 0.150 |
Why?
|
Catechol O-Methyltransferase | 1 | 2019 | 245 | 0.150 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 178 | 0.150 |
Why?
|
Vitamin B 12 | 2 | 2019 | 527 | 0.150 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 236 | 0.140 |
Why?
|
Dietary Fiber | 3 | 2015 | 760 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Genetic Loci | 3 | 2017 | 2575 | 0.140 |
Why?
|
Uric Acid | 1 | 2022 | 766 | 0.140 |
Why?
|
Antineoplastic Agents | 4 | 2024 | 13693 | 0.140 |
Why?
|
Raynaud Disease | 1 | 2017 | 75 | 0.140 |
Why?
|
BRCA1 Protein | 2 | 2016 | 1149 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 287 | 0.140 |
Why?
|
Flavonols | 1 | 2016 | 83 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.140 |
Why?
|
Tricarboxylic Acids | 1 | 2016 | 29 | 0.140 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2016 | 36 | 0.140 |
Why?
|
Cholesterol, LDL | 6 | 2016 | 2355 | 0.140 |
Why?
|
Catechin | 1 | 2015 | 66 | 0.130 |
Why?
|
Nonsteroidal Anti-Androgens | 1 | 2015 | 8 | 0.130 |
Why?
|
Young Adult | 22 | 2021 | 56429 | 0.130 |
Why?
|
Macular Degeneration | 2 | 2013 | 980 | 0.130 |
Why?
|
Hyperlipidemias | 3 | 2012 | 789 | 0.130 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 262 | 0.130 |
Why?
|
Methionine | 1 | 2018 | 590 | 0.130 |
Why?
|
Quercetin | 1 | 2015 | 93 | 0.130 |
Why?
|
Candy | 1 | 2014 | 37 | 0.130 |
Why?
|
Sex Characteristics | 3 | 2022 | 2585 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2021 | 658 | 0.130 |
Why?
|
Motor Vehicles | 1 | 1997 | 268 | 0.130 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2016 | 460 | 0.120 |
Why?
|
Vitamin B Complex | 1 | 2017 | 288 | 0.120 |
Why?
|
Accidental Falls | 1 | 2023 | 1062 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2018 | 847 | 0.120 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2016 | 315 | 0.120 |
Why?
|
Estradiol | 2 | 2020 | 2020 | 0.120 |
Why?
|
Leisure Activities | 1 | 2016 | 311 | 0.120 |
Why?
|
Fibrinolysis | 1 | 2015 | 322 | 0.120 |
Why?
|
Heart Failure | 5 | 2020 | 10895 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2016 | 658 | 0.120 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2014 | 88 | 0.120 |
Why?
|
Gastroenteritis | 1 | 2016 | 245 | 0.120 |
Why?
|
Lipoproteins, HDL | 3 | 2019 | 638 | 0.120 |
Why?
|
Trans-Activators | 2 | 2015 | 2926 | 0.120 |
Why?
|
China | 4 | 2021 | 2245 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2018 | 638 | 0.120 |
Why?
|
Trans Fatty Acids | 1 | 2015 | 153 | 0.120 |
Why?
|
Leukocytes | 2 | 2019 | 2045 | 0.120 |
Why?
|
Reproductive History | 1 | 2015 | 209 | 0.120 |
Why?
|
Alcohol Dehydrogenase | 1 | 2014 | 119 | 0.120 |
Why?
|
Tryptophan | 3 | 2023 | 478 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13991 | 0.120 |
Why?
|
Antibody Formation | 1 | 2018 | 1402 | 0.110 |
Why?
|
Insulin Resistance | 3 | 2014 | 3864 | 0.110 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 426 | 0.110 |
Why?
|
Iron | 1 | 2021 | 1774 | 0.110 |
Why?
|
Selenoprotein P | 1 | 2012 | 32 | 0.110 |
Why?
|
Hypogonadism | 1 | 2019 | 799 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 850 | 0.110 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 66 | 0.110 |
Why?
|
Prostatectomy | 4 | 2014 | 1890 | 0.110 |
Why?
|
Survival Analysis | 9 | 2020 | 10252 | 0.110 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11031 | 0.110 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1572 | 0.110 |
Why?
|
Folic Acid | 2 | 2018 | 1300 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 361 | 0.100 |
Why?
|
Adolescent | 20 | 2023 | 85779 | 0.100 |
Why?
|
Disease | 1 | 2017 | 680 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2036 | 0.100 |
Why?
|
Models, Cardiovascular | 2 | 2011 | 996 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 251 | 0.100 |
Why?
|
Waist-Hip Ratio | 3 | 2019 | 517 | 0.100 |
Why?
|
Lipogenesis | 1 | 2013 | 212 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2703 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10943 | 0.100 |
Why?
|
Neopterin | 2 | 2023 | 56 | 0.100 |
Why?
|
Universities | 5 | 2018 | 951 | 0.100 |
Why?
|
Boston | 5 | 2011 | 9312 | 0.100 |
Why?
|
Death Certificates | 3 | 2011 | 169 | 0.100 |
Why?
|
Body Height | 3 | 2015 | 1578 | 0.100 |
Why?
|
Placebos | 3 | 2019 | 1676 | 0.100 |
Why?
|
Nutrition Surveys | 2 | 2008 | 1660 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1813 | 0.100 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11366 | 0.100 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1151 | 0.090 |
Why?
|
Counseling | 2 | 2014 | 1523 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5077 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 2016 | 0.090 |
Why?
|
Epidemiologic Methods | 3 | 2019 | 1364 | 0.090 |
Why?
|
Metabolomics | 1 | 2019 | 1485 | 0.090 |
Why?
|
Eye Diseases | 1 | 2016 | 669 | 0.090 |
Why?
|
Patient Selection | 1 | 2002 | 4216 | 0.090 |
Why?
|
Weight Loss | 2 | 2020 | 2625 | 0.090 |
Why?
|
Diet, Fat-Restricted | 2 | 2012 | 320 | 0.090 |
Why?
|
Phenotype | 3 | 2018 | 16367 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1115 | 0.090 |
Why?
|
Neurotoxicity Syndromes | 1 | 2014 | 290 | 0.090 |
Why?
|
Milk | 1 | 2012 | 450 | 0.090 |
Why?
|
Beer | 2 | 2008 | 127 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1142 | 0.090 |
Why?
|
Selenium | 1 | 2012 | 405 | 0.090 |
Why?
|
Receptors, Fc | 1 | 2013 | 541 | 0.090 |
Why?
|
Atherosclerosis | 1 | 2006 | 3444 | 0.090 |
Why?
|
Kallikreins | 1 | 2011 | 258 | 0.090 |
Why?
|
Tissue Array Analysis | 3 | 2016 | 553 | 0.090 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.080 |
Why?
|
Wine | 2 | 2008 | 165 | 0.080 |
Why?
|
Comorbidity | 8 | 2018 | 10388 | 0.080 |
Why?
|
Australia | 3 | 2018 | 1167 | 0.080 |
Why?
|
Heptanoic Acids | 1 | 2011 | 343 | 0.080 |
Why?
|
Population Density | 1 | 2009 | 196 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2951 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9445 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 229 | 0.080 |
Why?
|
Alleles | 5 | 2019 | 6933 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7184 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2022 | 2166 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 402 | 0.080 |
Why?
|
Dyslipidemias | 2 | 2005 | 849 | 0.080 |
Why?
|
Models, Statistical | 2 | 2020 | 5101 | 0.080 |
Why?
|
Survival Rate | 8 | 2018 | 12788 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2020 | 5096 | 0.080 |
Why?
|
Internet | 1 | 2000 | 3056 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2012 | 488 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.080 |
Why?
|
Pilot Projects | 1 | 2021 | 8319 | 0.080 |
Why?
|
Linkage Disequilibrium | 3 | 2021 | 1997 | 0.070 |
Why?
|
Prevalence | 6 | 2023 | 15221 | 0.070 |
Why?
|
Antihypertensive Agents | 2 | 2015 | 2047 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3086 | 0.070 |
Why?
|
Alcoholic Beverages | 2 | 1999 | 265 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 950 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2014 | 7914 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
Apolipoprotein A-I | 2 | 2019 | 281 | 0.070 |
Why?
|
Malus | 2 | 2005 | 48 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10259 | 0.070 |
Why?
|
Bleomycin | 2 | 2018 | 512 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1018 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 878 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2010 | 781 | 0.070 |
Why?
|
Animals | 8 | 2019 | 168768 | 0.070 |
Why?
|
Etoposide | 2 | 2018 | 641 | 0.070 |
Why?
|
Asia | 2 | 2018 | 609 | 0.070 |
Why?
|
Public Health | 2 | 2014 | 2602 | 0.070 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 892 | 0.070 |
Why?
|
Death | 1 | 2010 | 678 | 0.070 |
Why?
|
Bicycling | 1 | 2007 | 176 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2200 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2428 | 0.070 |
Why?
|
Smoking Cessation | 2 | 2021 | 2071 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2011 | 972 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2850 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2014 | 3084 | 0.060 |
Why?
|
Databases, Factual | 1 | 2000 | 7730 | 0.060 |
Why?
|
DNA Methylation | 2 | 2016 | 4285 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 5984 | 0.060 |
Why?
|
Health Personnel | 2 | 2015 | 3219 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1146 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 12802 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2013 | 1373 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2375 | 0.060 |
Why?
|
Tocopherols | 1 | 2003 | 43 | 0.060 |
Why?
|
Self Disclosure | 1 | 2005 | 251 | 0.060 |
Why?
|
Age Distribution | 5 | 2011 | 2902 | 0.060 |
Why?
|
Brassica | 1 | 2003 | 38 | 0.060 |
Why?
|
Magnesium | 1 | 2006 | 813 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2022 | 63107 | 0.060 |
Why?
|
Parkinson Disease | 2 | 2007 | 2775 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 944 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1836 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2052 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2297 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2282 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2005 | 366 | 0.050 |
Why?
|
Carbonated Beverages | 1 | 2023 | 214 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1783 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2021 | 7882 | 0.050 |
Why?
|
Acetaminophen | 2 | 2022 | 545 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3922 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3707 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2013 | 8861 | 0.050 |
Why?
|
Genome, Human | 1 | 2015 | 4420 | 0.050 |
Why?
|
Coronary Artery Disease | 2 | 2019 | 6486 | 0.050 |
Why?
|
Cyclin T | 1 | 2021 | 20 | 0.050 |
Why?
|
Europe | 3 | 2018 | 3338 | 0.050 |
Why?
|
Menopause | 2 | 2020 | 1626 | 0.050 |
Why?
|
Adipokines | 1 | 2023 | 320 | 0.050 |
Why?
|
Meta-Analysis as Topic | 2 | 2016 | 1342 | 0.050 |
Why?
|
Sports | 3 | 2006 | 688 | 0.050 |
Why?
|
Triglycerides | 4 | 2016 | 2453 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2736 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 77460 | 0.050 |
Why?
|
Dietary Sucrose | 1 | 2003 | 246 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2006 | 3265 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 244 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2566 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1788 | 0.050 |
Why?
|
United States Social Security Administration | 1 | 2000 | 12 | 0.050 |
Why?
|
Sweetening Agents | 1 | 2023 | 296 | 0.050 |
Why?
|
Health Services | 1 | 2006 | 758 | 0.050 |
Why?
|
Body Constitution | 1 | 2001 | 278 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2010 | 1783 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 5023 | 0.050 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 468 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 15078 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5035 | 0.050 |
Why?
|
Computational Biology | 3 | 2019 | 3519 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6539 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3528 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1413 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5223 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14723 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 111 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 141 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 175 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 4043 | 0.040 |
Why?
|
Visual Acuity | 3 | 2013 | 2530 | 0.040 |
Why?
|
NAD | 1 | 2023 | 590 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 391 | 0.040 |
Why?
|
Genetic Markers | 2 | 2019 | 2634 | 0.040 |
Why?
|
Depression | 1 | 1998 | 7759 | 0.040 |
Why?
|
MMPI | 1 | 1998 | 86 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 284 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2148 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 160 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7785 | 0.040 |
Why?
|
Insulin | 3 | 2019 | 6582 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 240 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2003 | 905 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 94 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 821 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2018 | 118 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 13035 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1172 | 0.040 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 285 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 591 | 0.040 |
Why?
|
Speech Reception Threshold Test | 1 | 2016 | 17 | 0.040 |
Why?
|
Aconitic Acid | 1 | 2016 | 14 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.030 |
Why?
|
Isocitrates | 1 | 2016 | 24 | 0.030 |
Why?
|
Signal Transduction | 2 | 2018 | 23404 | 0.030 |
Why?
|
Massachusetts | 4 | 2011 | 8662 | 0.030 |
Why?
|
Family Health | 1 | 2001 | 1281 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5181 | 0.030 |
Why?
|
Drug Combinations | 2 | 2012 | 1958 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 577 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1800 | 0.030 |
Why?
|
Adenoma | 1 | 2006 | 2174 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2016 | 204 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 148 | 0.030 |
Why?
|
European Union | 1 | 2016 | 158 | 0.030 |
Why?
|
Cooperative Behavior | 2 | 2013 | 1504 | 0.030 |
Why?
|
Phlebotomy | 1 | 2016 | 141 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2540 | 0.030 |
Why?
|
Meat Products | 1 | 2015 | 99 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 977 | 0.030 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 158 | 0.030 |
Why?
|
Kidney Calculi | 1 | 2019 | 465 | 0.030 |
Why?
|
Phospholipids | 1 | 1999 | 784 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2647 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 711 | 0.030 |
Why?
|
Liver Diseases | 1 | 2023 | 1253 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1364 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2016 | 364 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7798 | 0.030 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2016 | 145 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1333 | 0.030 |
Why?
|
Albuminuria | 1 | 2018 | 681 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Blood Glucose | 3 | 2019 | 6254 | 0.030 |
Why?
|
Drinking | 1 | 2015 | 197 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3207 | 0.030 |
Why?
|
Orchitis | 1 | 2014 | 35 | 0.030 |
Why?
|
Epididymitis | 1 | 2014 | 37 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 927 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 211 | 0.030 |
Why?
|
Food | 1 | 2019 | 772 | 0.030 |
Why?
|
Habits | 1 | 2014 | 139 | 0.030 |
Why?
|
Klinefelter Syndrome | 1 | 2014 | 48 | 0.030 |
Why?
|
Catalase | 1 | 2014 | 221 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
Morbidity | 1 | 1999 | 1768 | 0.030 |
Why?
|
Gynecomastia | 1 | 2014 | 88 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 910 | 0.030 |
Why?
|
Laboratories | 1 | 2017 | 463 | 0.030 |
Why?
|
Proinsulin | 1 | 2013 | 133 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1862 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15535 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 255 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 399 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 65 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4851 | 0.030 |
Why?
|
Celiac Disease | 1 | 2020 | 785 | 0.030 |
Why?
|
Fatigue | 1 | 1999 | 1531 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 594 | 0.030 |
Why?
|
Veterans | 1 | 2006 | 2519 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1131 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2015 | 415 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1655 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1237 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 288 | 0.030 |
Why?
|
Diabetes Complications | 1 | 1999 | 1359 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2065 | 0.020 |
Why?
|
Cholesterol, VLDL | 1 | 2011 | 65 | 0.020 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2530 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 596 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1656 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1341 | 0.020 |
Why?
|
Serotonin | 1 | 2015 | 1017 | 0.020 |
Why?
|
Data Collection | 1 | 2000 | 3339 | 0.020 |
Why?
|
Body Composition | 1 | 2000 | 2402 | 0.020 |
Why?
|
Caffeine | 1 | 2015 | 699 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 783 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7282 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1677 | 0.020 |
Why?
|
Testis | 1 | 2014 | 804 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9240 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 881 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 16715 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1480 | 0.020 |
Why?
|
United Arab Emirates | 1 | 2009 | 42 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2012 | 940 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 367 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 46 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 780 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2011 | 486 | 0.020 |
Why?
|
Reproduction | 1 | 2014 | 668 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1572 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 12073 | 0.020 |
Why?
|
Glioblastoma | 2 | 2015 | 3481 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1420 | 0.020 |
Why?
|
Pain | 1 | 2023 | 4988 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2873 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2063 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1998 | 6036 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1911 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 644 | 0.020 |
Why?
|
Androgens | 1 | 2015 | 1281 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2916 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1655 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2304 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.020 |
Why?
|
Thinness | 1 | 2010 | 480 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1642 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 861 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1179 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4208 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 3024 | 0.020 |
Why?
|
Phytotherapy | 1 | 2008 | 298 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 13882 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6994 | 0.020 |
Why?
|
Cataract Extraction | 1 | 2010 | 481 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2015 | 2108 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2462 | 0.020 |
Why?
|
Recreation | 1 | 2006 | 115 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2432 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2638 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3873 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2012 | 19905 | 0.020 |
Why?
|
Proline | 1 | 2006 | 458 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9857 | 0.010 |
Why?
|
gamma-Tocopherol | 1 | 2003 | 31 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8642 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8385 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 2184 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10483 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2249 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6100 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9724 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3493 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 970 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 979 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3921 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3646 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5253 | 0.010 |
Why?
|
Tennis | 1 | 2000 | 22 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1873 | 0.010 |
Why?
|
Physical Exertion | 1 | 2003 | 695 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20130 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14561 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8340 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2008 | 2288 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.010 |
Why?
|
Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2684 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5717 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2001 | 676 | 0.010 |
Why?
|
Biomedical Research | 1 | 2013 | 3309 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2419 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 1203 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6366 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18034 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2506 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11486 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 3508 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25628 | 0.010 |
Why?
|
Interviews as Topic | 1 | 1999 | 2539 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35134 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 41005 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81201 | 0.000 |
Why?
|
Patient Discharge | 1 | 1999 | 3318 | 0.000 |
Why?
|